...
首页> 外文期刊>Modern Pathology >Loss of Fhit Expression in Testicular Germ Cell Tumors and Intratubular Germ Cell Neoplasia
【24h】

Loss of Fhit Expression in Testicular Germ Cell Tumors and Intratubular Germ Cell Neoplasia

机译:睾丸生殖细胞肿瘤和肾小管内生殖细胞瘤的Fhit表达丧失

获取原文

摘要

The FHIT gene, located at human chromosome 3p14.2, is frequently deleted in a number of human cancers, and interstitial deletions at this site were recently described in a significant proportion (41%) of testicular germ cell tumors. We studied the expression of Fhit protein in the progression and differentiation of testicular germ cell tumors to further elucidate its role in this type of malignancy. Forty-five patients with testicular germ cell tumors and intratubular germ cell neoplasia (identified in 42/45 cases) were included in the study. Immunohistochemical staining with polyclonal rabbit IgG antibody to Fhit (ZR44, Zymed Laboratories) on formalin-fixed, paraffin-embedded tissues was used. Fhit was constitutively expressed in germ cells, Sertoli cells, and Leydig cells. All 42 cases of intratubular germ cell neoplasia revealed no expression of this protein. No expression of Fhit was observed in any case of pure seminoma or in the seminomatous component of mixed germ cell tumors. Unexpectedly, Fhit expression was frequently (16/18) observed in the glandular tissue of mature teratomatous component of mixed germ cell tumors, despite the absence of Fhit in the intratubular germ cell neoplasia, the presumed precursor lesion. The loss of Fhit expression is a consistent characteristic of intratubular germ cell neoplasia, which suggests a potential role in a maturation/differentiation defect early in the development of testicular germ cell tumors. Likewise, the lack of expression in seminomas is supportive of this view. However, re-expression of Fhit in well-differentiated glandular epithelium of teratomatous component of mixed germ cell tumors suggests that there is no loss of FHIT gene in this subset of neoplasia but rather that Fhit protein expression is differently regulated through the phases of germ cell tumor progression.
机译:位于人类染色体3p14.2的FHIT基因在许多人类癌症中经常被删除,最近在睾丸生殖细胞肿瘤中有相当比例(41%)报道了该位点的间质性缺失。我们研究了Fhit蛋白在睾丸生殖细胞肿瘤的进展和分化中的表达,以进一步阐明其在这类恶性肿瘤中的作用。该研究纳入了45例睾丸生殖细胞肿瘤和肾小管内生殖细胞瘤的患者(确定为42/45例)。在福尔马林固定,石蜡包埋的组织上使用针对Fhit的多克隆兔IgG抗体(ZR44,Zymed Laboratories)进行免疫组织化学染色。 Fhit在生殖细胞,Sertoli细胞和Leydig细胞中组成性表达。所有42例肾小管内生殖细胞瘤均未发现该蛋白的表达。在纯精原细胞瘤或混合生殖细胞肿瘤的半裸成分中均未观察到Fhit表达。出乎意料的是,尽管混合型生殖细胞肿瘤的成熟畸胎瘤成分的腺组织中经常观察到Fhit表达(16/18),尽管在肾小管内生殖细胞瘤(假定的前体病变)中没有Fhit。 Fhit表达的丧失是肾小管内生殖细胞瘤形成的一致特征,表明睾丸生殖细胞肿瘤发展早期可能在成熟/分化缺陷中发挥作用。同样,精原细胞缺乏表达也支持这种观点。然而,Fhit在混合生殖细胞瘤的畸胎瘤成分的分化良好的腺上皮中的重新表达表明,在该瘤形成的子集中,FHIT基因没有丢失,而是通过生殖细胞的各个阶段来调节Fhit蛋白的表达。肿瘤进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号